First experience of a novel femorocrural expanded polytetrafluoroethylene bypass graft

Ann Vasc Surg. 2014 Apr;28(3):620-7. doi: 10.1016/j.avsg.2013.04.024. Epub 2013 Dec 17.

Abstract

Background: This study aims to evaluate early results of a precuffed expanded polytetrafluoroethylene (ePTFE) Distaflo® Mini-Cuff Bypass Graft versus autologous saphenous vein (ASV) grafting in patients with peripheral arterial obstructive disease (PAOD).

Methods: This retrospective single-center study analyzed 42 patients who received a femorocrural bypass graft because of PAOD using an ASV graft (n = 28) or Distaflo Mini-Cuff graft (n = 14).

Results: Primary patency rates in the ASV and Distaflo Mini-Cuff groups were 81% and 69%, respectively, after 6 months. Secondary patency rates were 81% and 35%, respectively, after 12 months. The limb salvage rate was 81% in the ASV group vs 65% and 35%, respectively, in the Distaflo Mini-Cuff group after 6 months and 1 year.

Conclusions: The ePTFE Distaflo Mini-Cuff is an option for revascularization in the absence of a suitable ASV. However, the performance of this novel graft is not better than that of current ePTFE bypass grafts.

Publication types

  • Comparative Study

MeSH terms

  • Aged
  • Aged, 80 and over
  • Autografts
  • Blood Vessel Prosthesis Implantation / adverse effects
  • Blood Vessel Prosthesis Implantation / instrumentation*
  • Blood Vessel Prosthesis*
  • Constriction, Pathologic
  • Female
  • Femoral Artery / physiopathology
  • Femoral Artery / surgery*
  • Humans
  • Limb Salvage
  • Male
  • Middle Aged
  • Netherlands
  • Peripheral Arterial Disease / diagnosis
  • Peripheral Arterial Disease / physiopathology
  • Peripheral Arterial Disease / surgery*
  • Polytetrafluoroethylene*
  • Prosthesis Design
  • Retrospective Studies
  • Saphenous Vein / transplantation*
  • Time Factors
  • Treatment Outcome
  • Vascular Patency

Substances

  • Polytetrafluoroethylene